MarketingRx roundup: Americans still divided over Covid boosters; Amgen ramps up activity on Threads
Covid vaccine makers Pfizer, Moderna and Novavax have all ramped up US marketing and advertising efforts this fall, but some Americans still aren’t convinced.
A new Ipsos poll finds 43% of Americans are likely to get a booster, but only 30% are “very likely” to get a booster shot. Meanwhile, a very solid 37% said they are “not at all likely” to get it. About 6% had already received a Covid booster by the poll taken the first week of October.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
